News and Events
- All
- Awards
- Community
- Network Profile
- Press Release
- Research Highlight
Gut enzymes could hold key to producing universal blood
Source: Reprinted with permission from the University of British Columbia, Faculty of Science. For blood transfusions to be safe, the donor and patient blood types …
Q and A with Network Investigator Mario Monteiro, Professor, University of Guelph
What was your reaction when you were awarded the recent 2018 RBC Top 25 Immigrants Award? I think that all human beings like to be recognized …
A pretty plant of summer produces a promising anti-diabetes compound
Discovery of the biosynthetic pathway of a plant metabolite lays the groundwork for its use as an anti-diabetes drug July 2, 2018 Roughly half of …
Relieving the pain of kidney stones
The power and promise of carbohydrate moleculesFor anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms. More stubborn stones can require surgery.GlycoNet-funded research is testing the safety and efficacy of a glycoside, called arbutin, which is extracted from the bearberry plant. The molecule has shown a remarkable ability to break up kidney stones in pre-clinical studies.
GlycoNet Network Investigators play prominent role at 101st Canadian Chemistry Conference
Several GlycoNet Network Investigators were front and centre in an organizing role during the 101st Canadian Chemistry Conference and Exhibition (CSC) in Edmonton. Dr. Chris …
Indigenization of chemistry education top of mind for science educators
Exploring reconciliation in chemistry education session co-led by GlycoNet Network Investigator by Bernie Poitras Indigenous leaders, researchers, educators and science leaders across Canada discussed the …
Science, scenery, socks and social networking
Third annual Canadian Glycomics Symposium & AGM wraps up in majestic Canadian Rockies by Bernie Poitras More than 225 participants took part in the 2018 …
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., …
Made to measure sugar-like molecule could improve cancer-fighting antibodies
GlycoNet funds project to produce fucosylation inhibitor for cancer therapies by Bernie Poitras Dr. Robert Britton firmly believes every molecule is important. This chemist …
GlycoNet Chair Frank Gleeson announces launch of Satellos Bioscience Inc.
We are delighted to congratulate our Chair, Frank Gleeson on the founding and launch of a new entrant on Canada’s biotechnology scene – Satellos …
Extraordinary $15 million gift will create unique powerhouse initiative to fight infections
Partnership will bring together over 250 researchers under the newly created McGill Interdisciplinary Initiative in Infection and Immunity
Carbohydrate biomarker improves screening for breast cancer patients
Precise blood test could prevent unnecessary cancer treatment
English 
French